Additional patient-related factors, such as tumor location, obesity, or the presence of hereditary or acquired thrombophilias (e.g., protein C or S deficiencies, factor V Leiden mutation), are recognized contributors [8]. This evidence concerns the gene F5 and obesity due to melanocortin 4 receptor deficiency.